Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.390
+0.010 (0.72%)
Feb 21, 2025, 4:00 PM EST - Market closed
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $83.51 million as of February 21, 2025. Its market cap has decreased by -54.79% in one year.
Market Cap
83.51M
Enterprise Value
-145.40M
1-Year Change
-54.79%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $83.51M, a decrease of -86.50%. That is a compound annual growth rate of -42.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 83.51M | -19.19% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 792.33B |
| UnitedHealth Group | 428.90B |
| Johnson & Johnson | 391.17B |
| Novo Nordisk | 370.84B |
| AbbVie | 357.84B |
| Abbott Laboratories | 234.06B |
| AstraZeneca | 229.50B |
| Merck & Co. | 224.96B |